IBM (IBM) director reports 338 deferred Promised Fee Shares in Form 4

Rhea-AI Filing Summary

International Business Machines Corp. director equity update: A director of IBM filed a Form 4 reporting a deferred compensation transaction dated 12/31/2025. The filing shows the director acquired 338 "Promised Fee Shares" at an exercise price of $0.00 under the IBM Board of Directors Deferred Compensation and Equity Award Plan, representing 338 shares of IBM common stock underlying the derivative security.

These Promised Fee Shares reflect a deferral of board fees into stock-based units rather than a market purchase or sale of IBM shares. Following this transaction, the director beneficially owned 31,422 derivative securities directly. Under the plan, payout or distribution of these Promised Fee Shares is deferred until the director’s retirement and can be settled in IBM common stock or cash.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

VOSER PETER R.

(Last) (First) (Middle)

C/O SECRETARY'S OFFICE, IBM CORPORATION

ONE NEW ORCHARD ROAD

(Street)

ARMONK NY 10504

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
INTERNATIONAL BUSINESS MACHINES CORP [ IBM ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
12/31/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Promised Fee Share	$0.00(1)	12/31/2025		A(2)		338		(3)	(3)	Common Stock	338	$296.21	31,422	D

Explanation of Responses:

1. Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan are paid out after retirement in the company's common stock or cash.

2. Deferral of fees into Promised Fee Shares under the terms of the IBM Board of Directors Deferred Compensation and Equity Award Plan.

3. Distribution of Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan is deferred until retirement.

Remarks:

	L. Mallardi on behalf of P. R. Voser	01/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did IBM (IBM) report in this Form 4?

The Form 4 reports that an IBM director acquired 338 Promised Fee Shares on 12/31/2025 under the IBM Board of Directors Deferred Compensation and Equity Award Plan.

Did the IBM director buy or sell common stock on the open market?

No. The reported activity involves Promised Fee Shares from deferring board fees under a compensation plan, not an open-market purchase or sale of IBM common stock.

How many IBM-related derivative securities does the director now hold?

After the reported transaction, the director beneficially owned 31,422 derivative securities directly, tied to IBM common stock under the compensation plan.

What are IBM Promised Fee Shares for directors?

Promised Fee Shares are units under the IBM Board of Directors Deferred Compensation and Equity Award Plan, representing deferred board fees payable in IBM common stock or cash after retirement.

When will the IBM director receive the Promised Fee Shares reported here?

The filing states that distribution of Promised Fee Shares under the plan is deferred until the director’s retirement.

What was the exercise or conversion price for the IBM Promised Fee Shares?

The Promised Fee Shares in this transaction carry a conversion or exercise price of $0.00, consistent with a fee deferral arrangement rather than a purchase.